CNS Stock Analysis: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$78.57
1.16 (1.50%)
▲
5d:
+2.72%
30d:
+10.35%
90d:
+26.46%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 16, 2026
10d
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CNS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CNS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$103.30
Based on 7.7% avg growth
INTRINSIC VALUE TODAY
$64.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $78.57, which is considered extended relative to its 30-day fair value range of $71.93 to $77.39. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.2) compared to its historical average (18.4). At these levels, the market is pricing in 3.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is approaching resistance at $78.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $70.33. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is approaching resistance at $78.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $70.33. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$71.93 -
$77.39
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.4%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 10.5% above Wall St target ($70.33)
- NEUTRAL: Market pricing in 3.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$71.93 -
$77.39
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$73.63
Resistance Level
$78.69
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.25
Wall Street Target
$70.33
(-10.5%)
Revenue Growth (YoY)
8.3%
Earnings Growth (YoY)
6.5%
Profit Margin
27.5%
Valuation Premium vs History
+3.2% premium
PE vs Historical
20.3 vs 18.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.2%
(market-implied from PE analysis)
1-Year Target
$81.08
(+3%)
2-Year Target
$83.68
(+7%)
3-Year Target
$86.36
(+10%)
3-Yr Target (if PE normalizes)
(PE: 20→18)
PE COMPRESSION
$78.47
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.4%)
$116.79
(+49%)
Base:
(SPY PE: 20.2, Growth: 11.4%)
$108.59
(+38%)
Bear:
(PE: 17.2, Growth: 11.4%)
$92.30
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 25.63 | Current EPS (TTM): $3.02
Bull Case
$109.40
(+39%)
Analyst growth 28.5%, PE expands to 28.2
Base Case
$99.45
(+27%)
Market implied 28.5%, PE stable at 25.6
Bear Case
$52.64
(-33%)
Severe decline -20.0%, PE contracts to 21.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 05, 2026 6:01 AM ET
Data refreshes hourly during market hours. Next update: 7:01 AM
Data refreshes hourly during market hours. Next update: 7:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis C Poli
SELL
10000 shares
2026-02-12
Francis C Poli
SELL
9696 shares
2026-02-11
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KKR
KKR & Co. Inc. |
STRONG BUY
21 analysts |
$126 | 53 HOLD |
|
APO
Apollo Global Management… |
STRONG BUY
19 analysts |
$150 | 55 HOLD |
|
HASI
Hannon Armstrong Sustain… |
STRONG BUY
16 analysts |
$49 | 58 HOLD |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$143 | 57 HOLD |
|
ARCC
Ares Capital Corporation |
STRONG BUY
13 analysts |
$21 | 60 HOLD |
